Evidence map›Paper›PMID 37939051›Full record

ArticlePLOS global public health2023

Current sampling and sequencing biases of Lassa mammarenavirus limit inference from phylogeography and molecular epidemiology in Lassa fever endemic regions.

Liã Bárbara Arruda, Hayley Beth Free, David Simons, Rashid Ansumana, Linzy Elton, Najmul Haider, Isobella Honeyborne, Danny Asogun, Timothy D McHugh, Francine Ntoumi and 2 more

Open access · goldAbstract read
In one paragraph

Article in PLOS global public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Lassa Fever: Critical Review and Prospects for Control.Tropical medicine and infectious disease · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 5 countries.

Liã Bárbara ArrudaDivision of Infection and Immunity, Centre for Clinical Microbiology, University College London, London, United Kingdom.ORCID https://orcid.org/0000-0003-3539-8154
Hayley Beth FreeThe Royal Veterinary College, University of London, Hatfield, United Kingdom.
David SimonsThe Royal Veterinary College, University of London, Hatfield, United Kingdom.ORCID https://orcid.org/0000-0001-9655-1656
Rashid AnsumanaSchool of Community Health Sciences, Njala University, Bo, Sierra Leone.
Linzy EltonDivision of Infection and Immunity, Centre for Clinical Microbiology, University College London, London, United Kingdom.ORCID https://orcid.org/0000-0003-4270-1553
Najmul HaiderThe Royal Veterinary College, University of London, Hatfield, United Kingdom.
Isobella HoneyborneDivision of Infection and Immunity, Centre for Clinical Microbiology, University College London, London, United Kingdom.
Danny AsogunEkpoma and Irrua Specialist Teaching Hospital, Ambrose Alli University, Irrua, Nigeria.
Timothy D McHughDivision of Infection and Immunity, Centre for Clinical Microbiology, University College London, London, United Kingdom.
Francine NtoumiFondation Congolaise Pour la Recherche Médicale (FCRM), Brazzaville, Republic of Congo.
Alimuddin ZumlaDivision of Infection and Immunity, Centre for Clinical Microbiology, University College London, London, United Kingdom.
Richard KockThe Royal Veterinary College, University of London, Hatfield, United Kingdom.ORCID https://orcid.org/0000-0002-6561-3209
University College London · GBUniversity of London · GBFondation Congolaise Pour La Recherche Médicale · CGIrrua Specialist Teaching Hospital · NGNjala University · SLUCL Biomedical Research Centre · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lassa fever (LF) is a potentially lethal viral haemorrhagic infection of humans caused by Lassa mammarenavirus (LASV). It is an important endemic zoonotic disease in West Africa with growing evidence for increasing frequency and sizes of outbreaks. Phylogeographic and molecular epidemiology methods have projected expansion of the Lassa fever endemic zone in the context of future global change. The Natal multimammate mouse (Mastomys natalensis) is the predominant LASV reservoir, with few studies investigating the role of other animal species. To explore host sequencing biases, all LASV nucleotide sequences and associated metadata available on GenBank (n = 2,298) were retrieved. Most data originated from Nigeria (54%), Guinea (20%) and Sierra Leone (14%). Data from non-human hosts (n = 703) were limited and only 69 sequences encompassed complete genes. We found a strong positive correlation between the number of confirmed human cases and sequences at the country level (r = 0.93 (95% Confidence Interval = 0.71-0.98), p < 0.001) but no correlation exists between confirmed cases and the number of available rodent sequences (r = -0.019 (95% C.I. -0.71-0.69), p = 0.96). Spatial modelling of sequencing effort highlighted current biases in locations of available sequences, with increased sequencing effort observed in Southern Guinea and Southern Nigeria. Phylogenetic analyses showed geographic clustering of LASV lineages, suggestive of isolated events of human-to-rodent transmission and the emergence of currently circulating strains of LASV from the year 1498 in Nigeria. Overall, the current study highlights significant geographic limitations in LASV surveillance, particularly, in non-human hosts. Further investigation of the non-human reservoir of LASV, alongside expanded surveillance, are required for precise characterisation of the emergence and dispersal of LASV. Accurate surveillance of LASV circulation in non-human hosts is vital to guide early detection and initiation of public health interventions for future Lassa fever outbreaks.

Identifiers

PMID37939051
PMCPMC10631635
OpenAlexW4388501181

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.